These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9869264)

  • 1. Effects of monatepil maleate, a new Ca2+ channel antagonist with alpha1-adrenoceptor antagonistic activity, on cholesterol absorption and catabolism in high cholesterol diet-fed rabbits.
    Ikeno A; Sumiya T; Minato H; Fujitani B; Masuda Y; Hosoki K; Kurono M; Yasuba M
    Jpn J Pharmacol; 1998 Nov; 78(3):303-12. PubMed ID: 9869264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-atherosclerotic and plasma lipid lowering effects of the novel calcium blocker with alpha 1-adrenoceptor antagonistic activity, monatepil, in high cholesterol diet-fed Japanese Macaca fuscata monkeys.
    Miyazaki M; Hosoki K; Okunishi H; Ishii K; Ikeno A; Okazaki Y
    Arzneimittelforschung; 1994 Mar; 44(3):288-97. PubMed ID: 8192692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive, antiatherosclerotic, and plasma lipid-lowering effects of monatepil, a novel calcium antagonist with alpha 1-adrenoceptor-blocking activity in experimental animals.
    Miyazaki M
    Am J Hypertens; 1994 Oct; 7(10 Pt 2):131S-40S. PubMed ID: 7826563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of monatepil maleate on acyl-CoA:cholesterol acyltransferase activity in the liver of cholesterol-fed Japanese monkeys.
    Sumiya T; Ikeno A; Kato H; Fujitani B; Masuda Y; Hosoki K; Miyazaki M
    Am J Hypertens; 1997 Jul; 10(7 Pt 1):779-85. PubMed ID: 9234833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on calcium antagonistic and alpha 1-adrenergic receptor blocking activities of monatepil maleate, its metabolites and their enantiomers.
    Honda Y; Masuda Y; Yoshida T; Sato F; Kurokawa M; Hosoki K
    Arzneimittelforschung; 1995 Oct; 45(10):1057-60. PubMed ID: 8595057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of hepatic LDL receptor gene expression by monatepil, a novel calcium antagonist, in high cholesterol diet-fed Japanese monkeys.
    Notake M; Kondo Y; Nomura H; Nakano K; Hosoki K; Miyazaki M
    Am J Hypertens; 1994 Nov; 7(11):1026-30. PubMed ID: 7848617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of monatepil, a novel calcium antagonist with alpha 1-adrenergic blocking activity, on the low-density lipoprotein receptor in human skin fibroblasts.
    Matsunaga A; Inoue T; Koga T; Mori K; Kugi M; Sasaki J; Arakawa K
    Cardiovasc Drugs Ther; 1997 Dec; 11(6):747-50. PubMed ID: 9512869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of lipid hydroperoxidation of low density lipoprotein by the Ca(2+)-channel and alpha 1-adrenoceptor antagonist monatepil maleate.
    Hayashi K; Kuga Y; Nomura S; Okura Y; Tanaka K; Yasunobu Y; Nomura K; Shingu T; Kuwashima J; Kajiyama G
    Arzneimittelforschung; 1996 Apr; 46(4):378-81. PubMed ID: 8740082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of monatepil, a novel calcium antagonist with alpha 1-adrenergic-blocking activity, and nitrendipine on lipoprotein and carbohydrate metabolism in patients with hypertension.
    Sasaki J; Ogihara T; Yokoyama M; Kajiyama G; Mashiba H; Sunaga T; Nonaka K; Shichiri M; Tanaka N; Arakawa K
    Am J Hypertens; 1994 Oct; 7(10 Pt 2):161S-166S. PubMed ID: 7826567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative contribution of alpha 1-adrenoceptor blocking activity to the hypotensive effect of the novel calcium antagonist monatepil.
    Sugimoto T; Hosoki K; Karasawa T
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):55-60. PubMed ID: 7564365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chylomicron metabolism in normal, cholesterol-fed, and Watanabe heritable hyperlipidemic rabbits. Saturation of the sequestration step of the remnant clearance pathway.
    Hussain MM; Innerarity TL; Brecht WJ; Mahley RW
    J Biol Chem; 1995 Apr; 270(15):8578-87. PubMed ID: 7721759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid composition of aorta of Watanabe heritable hyperlipemic and comparably hypercholesterolemic fat-fed rabbits. Plasma lipid composition determines aortic lipid composition of hypercholesterolemic rabbits.
    Rosenfeld ME; Chait A; Bierman EL; King W; Goodwin P; Walden CE; Ross R
    Arteriosclerosis; 1988; 8(4):338-47. PubMed ID: 3395270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High dose of fluvastatin sodium (XU62-320), a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, lowers plasma cholesterol levels in homozygous Watanabe-heritable hyperlipidemic rabbits.
    Kurokawa J; Hayashi K; Toyota Y; Shingu T; Shiomi M; Kajiyama G
    Biochim Biophys Acta; 1995 Oct; 1259(1):99-104. PubMed ID: 7492622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unexpected inhibition of cholesterol 7 alpha-hydroxylase by cholesterol in New Zealand white and Watanabe heritable hyperlipidemic rabbits.
    Xu G; Salen G; Shefer S; Ness GC; Nguyen LB; Parker TS; Chen TS; Zhao Z; Donnelly TM; Tint GS
    J Clin Invest; 1995 Apr; 95(4):1497-504. PubMed ID: 7706454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probucol selectively increases oxidation of atherogenic lipoproteins in cholesterol-fed mice and in Watanabe heritable hyperlipidemic rabbits.
    Lauridsen ST; Mortensen A
    Atherosclerosis; 1999 Jan; 142(1):169-78. PubMed ID: 9920518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of calcium antagonists and adrenergic antihypertensive drugs on plasma lipids and cellular cholesterol metabolism.
    Krone W; Müller-Wieland D; Nägele H; Behnke B; Greten H
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S199-202. PubMed ID: 2455133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive effect of a new calcium antagonist, monatepil, on drug-induced ischaemic electrocardiographic changes in rats.
    Yamamoto T; Nakatsuji K; Hosoki K; Karasawa T
    Clin Exp Pharmacol Physiol; 1993 Nov; 20(11):673-8. PubMed ID: 8306512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the new calcium antagonist monatepil on cardiac function and myocardial oxygen supply and demand in animals.
    Kataoka T; Nose I; Honda Y; Yamada T; Hatano N; Masuda Y; Hosoki K; Karasawa T
    Arzneimittelforschung; 1993 Dec; 43(12):1303-9. PubMed ID: 8141817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-lasting antagonistic effects of monatepil on Ca2+ current in guinea-pig ventricular cells.
    Nagata S; Hosoki K; Karasawa T
    Arzneimittelforschung; 1995 Oct; 45(10):1061-3. PubMed ID: 8595058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism study of chitosan on lipid metabolism in hyperlipidemic rats.
    Xu G; Huang X; Qiu L; Wu J; Hu Y
    Asia Pac J Clin Nutr; 2007; 16 Suppl 1():313-7. PubMed ID: 17392126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.